• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 102208-905
Device Problem Imprecision (1307)
Patient Problems Headache (1880); Hypoglycemia (1912)
Event Date 05/06/2023
Event Type  Injury  
Manufacturer Narrative
This report is being submitted retrospectively as part of internal review.The investigation was performed on the user synced glucose data on data management system (dms), which is an eversense cloud platform.Based on the investigation analysis, the reported sg value of 150 mg/dl at the time of incident could not be confirmed.Per dms, the sg value was 166 mg/dl at 5:31 pm and the bg fingerstick value of 185 mg/dl was entered at 5:40 pm.No high glucose alert was asserted during the time of incident as the sg value did not cross the high alert threshold that was set at 170 mg/dl.The investigation analysis did not reveal any malfunction as the overall system performance was within expectations.Overall, bg values entered as calibrations fit sg trends well and the occasional differences could be attributed to lag which is inherent to cgm system, and due to calibrations that were entered during the periods of rapid glucose changes.The eversense user guide recommends users to avoid calibrations during the period of rapid glucose changes.No further investigation was found necessary for this complaint.
 
Event Description
Senseonics was made aware of a customer experiencing a hypoglycemia events on (b)(6) 2023 at 5:33 pm.The customer reported that the measured blood glucose (bg) value was 185 mg/dl where as the sensor glucose (sg) reading was 150 mg/dl.The customer did not receive low glucose alert because the sg value did not cross above the high alert threshold which was set at 170 mg/dl.The customer had symptom of headache at the time of incident.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE TRANSMITTER
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20876-7005
MDR Report Key18117301
MDR Text Key327880199
Report Number3009862700-2023-00267
Device Sequence Number1
Product Code QHJ
Combination Product (y/n)Y
Reporter Country CodeIT
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 11/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/12/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date11/07/2023
Device Model Number102208-905
Device Catalogue NumberFG-3500-05-001
Device Lot Number133445
Was Device Available for Evaluation? No
Date Manufacturer Received08/04/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/07/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-